• OPEN AN ACCOUNT
Indian Indices
Sensex
78,648.77 219.82
( 0.28%)
Global Indices
Nasdaq
54,113.09 913.68
(1.72%)
Dow Jones
7,758.57 137.07
(1.80%)
Hang Seng
63,983.92 229.02
(0.36%)
Nikkei 225
10,890.39 32.69
(0.30%)
Forex
USD-INR
95.29 -0.10
(-0.11%)
EUR-INR
109.78 -0.22
(-0.20%)
GBP-INR
128.18 -0.43
(-0.33%)
JPY-INR
0.61 0.00
(0.31%)

EQUITY - MARKET SCREENER

Ishita Drugs & Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524400
INE806D01016
38.6956522
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
29.92
23.26
EPS(TTM)
Face Value()
Div & Yield %
2.6
10
0
 

Vivanza Biosciences reports consolidated net loss of Rs 0.45 crore in the March 2026 quarter
May 08,2026
Net Loss of Vivanza Biosciences reported to Rs 0.45 crore in the quarter ended March 2026 as against net loss of Rs 1.00 crore during the previous quarter ended March 2025. Sales rose 1225.00% to Rs 6.36 crore in the quarter ended March 2026 as against Rs 0.48 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.39 crore in the year ended March 2026 as against net loss of Rs 0.67 crore during the previous year ended March 2025. Sales rose 1462.13% to Rs 115.91 crore in the year ended March 2026 as against Rs 7.42 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales6.360.48 1225 115.917.42 1462
OPM %-3.62-200.00 -0.63-4.85 -
PBDT-0.29-0.99 71 0.57-0.65 LP
PBT-0.30-0.99 70 0.54-0.67 LP
NP-0.45-1.00 55 0.39-0.67 LP